Community willingness to participate in a Nipah vaccine trial in Bangladesh
Many respondents expressed willingness to participate in a NiV vaccine trial, especially during an outbreak, suggesting that such a trial may be feasible in Bangladesh. Given concerns about safety and side effects, clear communication on these issues may support informed participation.
Authors
- Gray Heppner
- Shahana Parveen (ORCID: https://orcid.org/0000-0001-9239-1691)
- Tahmina Shirin (ORCID: https://orcid.org/0000-0002-5061-3783)
- Brian E. Dawes (ORCID: https://orcid.org/0000-0001-7847-7376)
- Joan Fusco (ORCID: https://orcid.org/0000-0003-3716-5688)
- Atique Iqbal Chowdhury (ORCID: https://orcid.org/0000-0001-9140-5983)
- Zubair Akhtar
- Kanij Fatema Chanda
- Sayera Banu (ORCID: https://orcid.org/0000-0001-7810-8183)
- Ishrat Jabeen (ORCID: https://orcid.org/0000-0002-6660-6764)
- Nazmun Nahar (ORCID: https://orcid.org/0000-0002-4530-6009)
- Mohammad Saeed Munim
- Thomas P. Monath (ORCID: https://orcid.org/0000-0001-7509-4599)
- Md. Wazed Ali
- Probir Kumar Ghosh (ORCID: https://orcid.org/0000-0003-1580-5883)
- Asraful Alam
- Stephen P. Luby
- Emily S Gurley
- Farhat Jahan
- Md Rifat Haidar
Institutions
- Institute of Epidemiology, Disease Control and Research (BD)
Publication Details
- Journal
- Vaccine
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1016/j.vaccine.2025.127578
- Citations
- 1
- Primary Topic
- Virology and Viral Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.35